prior authorizations; habilitative services
HB2250 makes several changes to Arizona’s health insurance prior authorization laws. The bill requires health care insurers and utilization review agents to honor a prior authorization granted by a previous plan for at least 90 days after a member enrolls in a new plan, so long as the service remains a covered benefit and documentation is provided. It also protects enrollees from having to repeat step therapy in certain circumstances, and it limits the effect of changes in coverage or approval criteria for recently authorized services.
The bill further reduces prior authorization burdens for rehabilitative and habilitative services by prohibiting prior authorization for the first 12 visits of a new episode of care for physical therapy or occupational therapy. It also creates a provider exemption from prior authorization requirements for 12 months when a provider has at least a 90% approval rate for a particular service and has submitted at least five requests in the prior year, with notice, appeal, and revocation procedures. In addition, the bill shortens response deadlines for urgent and non-urgent prior authorization requests, requires clearer disclosure of prior authorization rules, and preserves existing appeal and review processes.
HB2250 would amend multiple sections of Title 20 governing utilization review, prior authorization timelines, disclosures, and chronic pain medication authorizations. It would also codify that a granted or deemed granted prior authorization is binding unless there is fraud or misrepresentation, and it would require statistical reporting to the department on prior authorization activity. The bill does not create a new private right of action, and it preserves insurer authority to deny claims later if services are found not medically necessary.
The general sentiment reflected in the committee vote was strongly favorable: the House Health & Human Services Committee approved the bill 12-0. The available record shows no recorded opposition in committee and no transcripted debate, suggesting broad support at that stage. The DPA/SE status indicates the bill was advanced with amendments and/or a strike-everything approach, which may reflect technical or policy refinements rather than substantive resistance.
The main points of contention likely center on the balance between patient access and insurer utilization management. Supporters would view the bill as reducing delays, improving continuity of care, and easing administrative burdens for providers and patients. Potential concerns for insurers are the shortened review deadlines, automatic approval consequences for missed deadlines, limits on prior authorization for therapy visits, and the provider exemption framework, which could reduce plan control over cost and medical-necessity review.
The bill would amend Arizona’s health insurance utilization review statutes in Title 20 by adding new continuity-of-care, therapy-access, and provider-exemption provisions, while also tightening prior authorization disclosure and turnaround requirements. It would affect health care insurers, health care services plans, utilization review agents, providers, and enrollees, especially in the areas of physical therapy, occupational therapy, step therapy, chronic pain prescriptions, and appeal procedures. The bill would also require insurers to honor certain prior authorizations across plan changes and would make prior authorizations binding once granted or deemed granted, subject to fraud or misrepresentation exceptions.
The available committee history suggests the bill was received positively, with unanimous approval in the House Health & Human Services Committee (12-0). No committee transcript is available, but the vote indicates little visible opposition at that stage. The DPA/SE action suggests the measure may have been refined in committee, which is consistent with a generally supportive but policy-specific legislative process.
The likely areas of contention are the bill’s limits on prior authorization and the extent to which it constrains insurer review authority. Insurers and utilization review entities may object to the 90-day continuity requirement, the 12-visit therapy exemption, the automatic provider exemption for high-approval-rate providers, and the shortened response deadlines, all of which could reduce administrative control and increase utilization. Patient advocates, providers, and supporters are likely to favor these provisions as reducing delays, administrative burden, and treatment interruptions, particularly for habilitative and rehabilitative care and for patients changing health plans.